NSRX vs MDCX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 25, 2026

NSRX

54.4
AI Score
VS
NSRX Wins

MDCX

29.7
AI Score

Investment Advisor Scores

NSRX

54score
Recommendation
HOLD

MDCX

30score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NSRX MDCX Winner
Net Income -5.86M -20.66M NSRX
Operating Income -4.90M -20.08M NSRX
ROE -211.6% 1171.4% MDCX
ROA -117.0% -76.2% MDCX
Total Assets 5.00M 27.12M MDCX
Cash 1.24M 15.17M MDCX
Current Ratio 2.24 1.57 NSRX

Relative Price Performance (Last 90 Days)

NSRX 1M: +0.3% · 3M: +12.9% MDCX 1M: +1474.3% · 3M: +685.7%

Current Technical Phase

NSRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.1 · Price: $3.49

MDCX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (193.2% over 20 days), RSI 65

RSI (14): 65.3 · Price: $2.50

Fundamentals Snapshot

Metric NSRX MDCX
Market Cap — —
Forward P/E -3.1 -0.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.20 -119.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NSRX is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.